The News Scroll 21 October 2019  Last Updated at 10:55 am | Source: PTI

Granules gets USFDA nod for allergy treatment drug

Granules gets USFDA nod for allergy treatment drug
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Oct 21 (PTI) Drug firm Granules India on Monday said it has received approval from the US health regulator for Fexofenadine Hydrochloride tablets, used to treat allergy symptoms.

The approved product is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC.

The US Food & Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by Granules India for Fexofenadine Hydrochloride tablets USP in the strengths of 60 mg and 180 mg (OTC), Granules said in a regulatory filing. PTI SVK ANS ANS


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI
Next Story : Michelle Pfeiffer recounts ''inappropriate'' moment with ''high powered'' industry person
Download the Outlook ​Magazines App. Six magazines, wherever you go! Play Store and App Store